Gill H
Mood Disorder and Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada. Electronic address: hartej.gill@utoronto.ca.
ArticlePsilocybin
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
ArticlePsilocybin
A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review.
ArticlePsilocybin
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.
ArticlePsilocybin
Registered clinical studies investigating psychedelic drugs for psychiatric disorders.
ArticlePsilocybin